To investigate the potential role of CYP1A1 A-to-I RNA editing in tumorigenic properties in NSCLC, RNA-seq was performed to compare A549 and A549I462V cells to further elucidate the involvement of CYP1A1 overediting in tumor progression (Fig. 5A). The gene discussed is CYP1A1; the disease is neoplasm.